| Literature DB >> 29445656 |
Hossein Sanaei-Zadeh1, Sayed Mahdi Marashi1, Rouhullah Dehghani2.
Abstract
Background: Scorpionism is a public health problem in some provinces in Iran. The present study aimed to assess the clinical manifestations of scorpion envenomation in Shiraz and determine a clinical severity grading for Iranian scorpion envenomation in order to suggest a treatment guideline for emergency physicians.Entities:
Keywords: Clinical Manifestations; Clinical Severity Grading; Epidemiology; Iran; Scorpion Stings; Scorpions
Year: 2017 PMID: 29445656 PMCID: PMC5804458 DOI: 10.18869/mjiri.31.27
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Medically important scorpions of Iran and clinical manifestations of their stings (9-12,14-33)
|
| Apparent color | Size | Clinical manifestations of the sting |
|
| Yellow |
Male: 5cm |
|
|
| Black | 11-12cm |
|
|
| Yellow | 12-13 cm | Severe pain at the site of the sting, other clinical manifestations (are questionable) |
|
| Yellow | 7-8.5 cm | Prolonged severe pain at the site of sting with radiation to its periphery, severe muscle contractions in the affected extremity (twitching), irritability, restlessness, tachycardia, tachypnea, dyspnea, unilateral acute pulmonary edema |
|
| Yellow | 5-6 cm |
|
|
| Black | 2.5-4 cm | Severe pain and prolonged itching at the site of sting, one death has been reported |
|
| Yellow | 7-8 cm | Anxiety, miosis, rhinorrhea, dacryorrhea, hypersalivation, tachypnea, shortness of breath, wheezing, gastric distention, and abdominal bulge |
|
| Yellow | 6-6.5 cm | Similar to the Mesobuthus eupeus |
|
| Yellow |
Male: 5cm | Similar to the Hemiscorpius lepturus, one death has been reported |
|
| Black | 13 cm | Not reported |
|
| Yellow | 4-5 cm | Hematuria (is questionable) |
DIC: disseminated intravascular coagulation; ECG: electrocardiographic; HUS: hemolytic uremic syndrome; PT: prothrombin time; PTT: partial prothrombin time
Fig. 1
Fig. 5Comparison of clinical manifestations of scorpion stings with respect to the scorpions’ color and size
| Clinical manifestations |
Yellow scorpions |
Hottentotta scorpions |
|
| Local pain | 37 (46.3%) | 4 (26.7%) | 0.130 |
| Burning sensation | 34 (42.5%) | 3 (20%) | 0.085 |
| Mild erythema | 26 (32.5%) | 4 (26.7%) | 0.454 |
| Severe local pain (with or without radiation to its periphery) | 20 (25%) | 9 (60%) | 0.010 |
| Mild swelling | 10 (12.5%) | 2 (13.3%) | 0.602 |
| Local pruritus | 6 (7.5%) | 1 (6.7%) | 0.695 |
| Local paresthesia | 1 (1.3%) | 0 (0%) | 0.842 |
| Nausea | 5 (6.3%) | 0 (0%) | 0.415 |
| Fatigue | 2 (2.5%) | 1 (6.7%) | 0.406 |
| Dyspnea | 1 (1.3%) | 0 (0%) | 0.842 |
| Vertigo | 2 (2.5%) | 1 (6.7%) | 0.406 |
| Sweating | 1 (1.3%) | 0 (0) | 0.842 |
| Shivering | 0 (0%) | 1 (6.7%) | 0.158 |
| Chest pain | 1 (1.3%) | 0 (0%) | 0.842 |
| Flushing | 1 (1.3%) | 0 (0%) | 0.842 |
| Epigastric pain | 1 (1.3%) | 0 (0%) | 0.842 |
| Muscle spasm | 1 (1.3%) | 0 (0%) | 0.842 |
| Pulse rate/min (mean ±SD) | 82.50±12.81 | 86.57±10.88 | 0.828 |
| Respiratory rate/min (mean ±SD) | 18.06±2.20 | 17.42±2.06 | 0.792 |
| Systolic blood pressure (mmHg) (mean ±SD) | 117.01±16.02 | 127.21±16.42 | 0.791 |
| Diastolic blood pressure (mmHg) (mean ±SD) | 76.00±14.60 | 80.42±10.72 | 0.297 |
| Microscopic hematuria | 9 (11.3%) | 0 (0%) | 0.197 |
| Severity grade I | 42 (52.5%) | 6 (40%) | 0.272 |
| Severity grade II | 27 (33.8%) | 8 (53.3%) | 0.126 |
| Severity grade III | 11 (13.8%) | 1 (6.7%) | 0.398 |
| Length of ED stay (˂6h) | 51 (71.8%) | 9 (60%) | 0.270 |
| Scorpion antivenin administrated | 1 (1.3%) | 4 (26.7%) | 0.002 |
SD: standard deviation; ED: emergency department
Grades of scorpion sting severity on the basis of the reported clinical manifestations of scorpion-stung patients from Iran (9-12,14-33)
| Grade | Clinical picture |
|
| • Mild localized symptoms |
|
|
• Moderate to severe local pain |
|
|
• Prolonged severe pain at the site of sting with radiation to its periphery (not responding to treatment), |
|
|
• Severe cutaneous manifestations (in endemic regions for |
DIC: disseminated intravascular coagulation; HUS: hemolytic uremic syndrome